[Glücksball]

Der Start war schwach, da kann man Kritikern zustimmen. Aber der Ausblick ist nun wirklich nicht so schlecht. Nimmt man z.B. nur mal BioNTech/Pfizer, dann geht es jetzt in Kürze in Marburg los:
https://investors.biontech.de/news-r...g-site-marburg

We started the manufacturing process at the Marburg facility with the execution of the first step: the production of mRNA, which is the active pharmaceutical ingredient of the Pfizer-BioNTech COVID-19 vaccine.

With Pfizer, we are working continuously on multiple initiatives to respond to global demand. We have increased our manufacturing capacity to up to 2 billion doses of our COVID-19 vaccine for 2021, assuming continuous process improvements, expansion at current facilities and adding new suppliers and contract manufacturers, and the updated six-dose labeling. A key factor in the expansion of our manufacturing network has been the set-up of this new manufacturing site in Marburg, Germany. This new BioNTech site will become one of the largest mRNA manufacturing sites in Europe with an annual production capacity of up to 750 million doses of our COVID-19 vaccine, once fully operational. BioNTech plans to be able to produce up to 250 million doses of BNT162b2 in the first half of 2021. The first vaccines manufactured at the Marburg site are scheduled for distribution in early April.

Wie immer kann in der wirklichen Welt einiges schief gehen. Aber die sind ja nicht die einzigen Produzenten. Ich vermute, spätestens ab Q3 haben wir reichlich Impfstoff. Dann heißt es hoffen, dass das Virus nicht zu schnell in schädlicher Weise mutiert.